A bicenter study on adjuvant surgery following treatment with tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma.
Fiche publication
Date publication
avril 2018
Journal
Interactive cardiovascular and thoracic surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel
Tous les auteurs :
Fournel L, Falcoz PE, Mansuet-Lupo A, Garelli E, Lococo F, Alifano M
Lien Pubmed
Résumé
A small number of patients with advanced pulmonary adenocarcinomas treated with tyrosine kinase inhibitors (TKIs) was subsequently considered eligible for surgery. Our goal was to report the clinical characteristics, pathological features and prognosis of these patients with the aim of exploring the feasibility of this strategy of care.
Référence
Interact Cardiovasc Thorac Surg. 2018 Apr 16;: